Stocksigma LogoStocksigma Logo

Welcure Drugs & Pharmaceuticals Ltd - Financial Result for the Quarter ended 31st Mar'26

■ Revenue: 0.0 (-100.0% YoY) ■ EBITDA: -4,986 (Profit to Loss YoY | -147856.7% QoQ) ■ EBITDA Margin (%): 0.0 (-300 bps YoY) ■ PAT: -4,986 (Profit to Loss

Welcure Drugs & Pharmaceuticals Ltd - Financial Result for the Quarter ended 31st Mar'26

Welcure Drugs & Pharmaceuticals Ltd · Outcome · 30 May 2026, 1:31 am

Welcure Drugs & Pharmaceuticals Ltd - Financial Result for the Quarter ended 31st Mar'26 (Standalone, INR Lacs) ■ Revenue: 0.0 (-100.0% YoY) ■ EBITDA: -4,986 (Profit to Loss YoY | -147856.7% QoQ) ■ EBITDA Margin (%): 0.0 (-300 bps YoY) ■ PAT: -4,986 (Profit to Loss YoY | Profit to Loss QoQ) ■ EPS (INR): -0.40 (Profit to Loss YoY | Profit to Loss QoQ) Welcure Drugs & Pharmaceuticals Ltd - Financial Result for the Quarter ended 31st Mar'26 (Standalone, INR Lacs) Segmental Performance Agriculture ■ Revenue: 0.0 (-100.0% YoY | -100.0% QoQ) ■ EBITDA: -4,986 (Profit to Loss YoY | Profit to Loss QoQ) ■ EBITDA Margin (%): 0.0 (-1099 bps YoY | -9736 bps QoQ) Drugs and Pharmaceuticals ■ Revenue: 0.0 ■ EBITDA: 0.0 ■ EBITDA Margin (%): 0.0

Original exchange filing (PDF)

More announcements from Welcure Drugs & Pharmaceuticals Ltd

All Welcure Drugs & Pharmaceuticals Ltd announcements